KRRO Korro Bio Inc reports smaller than projected Q4 2025 loss shares rise nearly 7 percent on investor optimism How Materion MTRN handles its debt maturity schedule Q1 2026 Earnings Beat Estimates STEW SRH Total quarterly results lack key metrics as investors await updated fund performance data and market outlook Aimco AIV Drifts Near 424 as Market Awaits Catalyst 20260521 Wells Fargo Reaches 110M Settlement Over Alleged Lending and Hiring Discrimination Elon Musk Loses OpenAI Lawsuit But Legal Battles Likely to Continue Short Sellers Target Fake AI Stocks as Tech Mania Creates Bearish Opportunities Jim Cramer Highlights Equinix as a Strategic Data Center Investment Play Oils Sudden Reversal Highlights Persistent Geopolitical Premium in Crude Markets Shein Acquires Sustainable Brand Everlane in FastFashion Shakeup Artha Venture Funds EarlyStage Strategy Spotting Winnable Ideas Before Market Readiness Reddit Stock Slides Nearly 6 After Meta Launches Standalone Forum App US Jobless Claims Drop to Lowest Level Since MidMay Signaling Labor Market Resilience LKQ Q1 2026 Earnings EPS Misses Estimates by 245 as Stock Edges Higher Essential Utilities Q1 2026 Earnings EPS Misses Analysts Expectations Despite Modest Stock Gain XOMAP Q1 2026 Earnings Perpetual Preferred Faces Steep EPS Miss Amid Limited Revenue Visibility RDZN Q1 2026 Earnings Significant EPS Miss Amidst Transition OneSpan OSPN Q1 2026 Earnings EPS Surpasses Estimates on Strong Operational Execution BCML Q1 2026 Earnings Strong EPS Surprise Driven by Net Interest Income and Credit Quality Moolec Science Warrant MLECW Holds at Penny Levels as Declines Exceed 5 NCA Edges Lower Amidst Municipal Bond Headwinds Key Levels in Focus Plum Acquisition Corp IV Unit PLMKU Holds Steady at 1088 as Market Awaits Catalyst American Well Corporation AMWL Surges Over 4 Breaking Out or Bouncing Back MMU Edges Higher in Modest Rally Municipal Bond Fund Shows Resilience David Einhorns Hedge Fund Greenlight Capital Takes Bullish Stance on Major Mall Retail Stock SCCE Q1 2026 Earnings Massive EPS Miss Signals Operational Challenges Amylyx Pharmaceuticals AMLX Slips 25 as Biotech Sector Faces Renewed Scrutiny